Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

被引：0
|
作者：
Laure Gossec
Stefan Siebert
Paul Bergmans
Kurt de Vlam
Elisa Gremese
Beatríz Joven-Ibáñez
Tatiana V. Korotaeva
Frederic Lavie
Wim Noël
Michael T. Nurmohamed
Petros P. Sfikakis
Mohamed Sharaf
Elke Theander
Josef S. Smolen
机构：
[1] Sorbonne Université,Rheumatology Department
[2] INSERM,Fondazione Policlinico A Gemelli
[3] Institut Pierre Louis d’Epidémiologie et de Santé Publique,IRCCS
[4] Pitié-Salpêtrière Hospital,undefined
[5] APHP,undefined
[6] 47–83 Boulevard de l’Hôpital,undefined
[7] University of Glasgow,undefined
[8] Janssen-Cilag BV,undefined
[9] University Hospitals Leuven,undefined
[10] Università Cattolica del Sacro Cuore,undefined
[11] University Hospital,undefined
[12] VA Nasonova Research Institute of Rheumatology,undefined
[13] The Janssen Pharmaceutical Companies of Johnson & Johnson,undefined
[14] Janssen Pharmaceutica NV,undefined
[15] Reade and VU University Medical Center,undefined
[16] National and Kapodistrian University of Athens Medical School,undefined
[17] Johnson and Johnson MEA,undefined
[18] Janssen,undefined
[19] Present address: Malmö University Hospital,undefined
[20] Medical University of Vienna,undefined
来源：
Arthritis Research & Therapy | / 25卷
关键词：
Patient-reported outcomes; Psoriatic arthritis; Real-world evidence; Tumour necrosis factor inhibitor; Ustekinumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
  • [1] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana V.
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Sharaf, Mohamed
    Theander, Elke
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [2] Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
    Gossec, Laure
    Theander, Elke
    Chakravarty, Soumya D. D.
    Bergmans, Paul
    Lavie, Frederic
    Noel, Wim
    Sharaf, Mohamed
    Siebert, Stefan
    Smolen, Josef S. S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [3] Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
    Laure Gossec
    Elke Theander
    Soumya D. Chakravarty
    Paul Bergmans
    Frederic Lavie
    Wim Noël
    Mohamed Sharaf
    Stefan Siebert
    Josef S. Smolen
    Arthritis Research & Therapy, 25
  • [4] Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Lubrano, Ennio
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
    Napolitano, Maddalena
    Costa, Luisa
    Caso, Francesco
    Megna, Matteo
    Scarpa, Raffaele
    Balato, Nicola
    Ayala, Fabio
    Balato, Anna
    CLINICAL RHEUMATOLOGY, 2017, 36 (07) : 1589 - 1593
  • [6] Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
    Maddalena Napolitano
    Luisa Costa
    Francesco Caso
    Matteo Megna
    Raffaele Scarpa
    Nicola Balato
    Fabio Ayala
    Anna Balato
    Clinical Rheumatology, 2017, 36 : 1589 - 1593
  • [7] Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis
    Nakagawa, Hidemi
    Tanaka, Yoshiya
    Sano, Shigetoshi
    Kameda, Hideto
    Taniguchi, Atsuo
    Kashiwagi, Tomoko
    Kawaberi, Takeshi
    Kimura, Junko
    Morita, Akimichi
    ADVANCES IN THERAPY, 2019, 36 (03) : 691 - 707
  • [8] Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis
    Hidemi Nakagawa
    Yoshiya Tanaka
    Shigetoshi Sano
    Hideto Kameda
    Atsuo Taniguchi
    Tomoko Kashiwagi
    Takeshi Kawaberi
    Junko Kimura
    Akimichi Morita
    Advances in Therapy, 2019, 36 : 691 - 707
  • [9] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Vibeke Strand
    Evo Alemao
    Thomas Lehman
    Alyssa Johnsen
    Subhashis Banerjee
    Harris A. Ahmad
    Philip J. Mease
    Arthritis Research & Therapy, 20
  • [10] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Strand, Vibeke
    Alemao, Evo
    Lehman, Thomas
    Johnsen, Alyssa
    Banerjee, Subhashis
    Ahmad, Harris A.
    Mease, Philip J.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
1234